Development and validation of an interpretable multi-task model to predict outcomes in patients with rhabdomyolysis: a multicenter retrospective cohort studyResearch in context

Summary: Background: Rhabdomyolysis (RM) is a complex clinical syndrome with heterogeneous progression patterns among patients of varying severity. Early and accurate prediction of acute kidney injury (AKI), disease severity, renal replacement therapy (RRT) requirements, and mortality risk is essen...

Full description

Saved in:
Bibliographic Details
Main Authors: Chunli Liu, Jie Shi, Fengjuan Wang, Duo Li, Yu Luo, Bofan Yang, Yunlong Zhao, Li Zhang, Dingwei Yang, Heng Jin, Jie Song, Xiaoqin Guo, Haojun Fan, Qi Lv
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537025003700
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849229210168590336
author Chunli Liu
Jie Shi
Fengjuan Wang
Duo Li
Yu Luo
Bofan Yang
Yunlong Zhao
Li Zhang
Dingwei Yang
Heng Jin
Jie Song
Xiaoqin Guo
Haojun Fan
Qi Lv
author_facet Chunli Liu
Jie Shi
Fengjuan Wang
Duo Li
Yu Luo
Bofan Yang
Yunlong Zhao
Li Zhang
Dingwei Yang
Heng Jin
Jie Song
Xiaoqin Guo
Haojun Fan
Qi Lv
author_sort Chunli Liu
collection DOAJ
description Summary: Background: Rhabdomyolysis (RM) is a complex clinical syndrome with heterogeneous progression patterns among patients of varying severity. Early and accurate prediction of acute kidney injury (AKI), disease severity, renal replacement therapy (RRT) requirements, and mortality risk is essential for timely identification of high-risk individuals, personalized treatment planning, and optimal allocation of healthcare resources. We aimed to develop and externally validate an interpretable multi-task machine learning (ML) model to predict four clinical outcomes in patients with rhabdomyolysis: AKI, disease severity, the need for RRT, and in-hospital mortality. Methods: We conducted a retrospective study using three data sources: the eICU Collaborative Research Database (eICU-CRD), the Medical Information Mart for Intensive Care IV (MIMIC-IV), and electronic medical records from four tertiary hospitals in China. Data from eICU-CRD and MIMIC-IV were combined to form the derivation cohort for model training and internal validation, while data from the Chinese hospitals served as the external validation cohort. We analyzed 1429 patients from 2008 to 2019 in the derivation cohort and 362 patients from 2016 to 2022 in the external validation cohort. AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria, based on serum creatinine levels and urine output. Twenty-two clinical features available within the first 24 h of admission were selected to develop the prediction models. Ten machine learning (ML) algorithms were applied to construct multi-task prediction models. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC). To improve interpretability, feature importance was assessed using the SHapley Additive exPlanation (SHAP) method. Findings: 1429 patients were included in the derivation cohort (69.4% developed AKI, 36.7% were classified as having severe disease, 12.1% required RRT, and 9.8% had in-hospital mortality). 362 patients were included in the external validation cohort (27.9% developed AKI, 25.7% had severe disease, 27.3% required RRT, and 4.1% had in-hospital mortality). Among all evaluated models, the random forest (RF) algorithm exhibited the highest overall discriminative performance across the four prediction tasks. Based on feature importance rankings, interpretable final models were developed for each task using the top five contributing features. These models demonstrated robust predictive accuracy for AKI, disease severity, RRT requirements, and in-hospital mortality, with AUCs and corresponding 95% confidence intervals (CIs) of 0.914 (0.875–0.944), 0.909 (0.869–0.940), 0.888 (0.844–0.921), and 0.823 (0.773–0.865) in the internal validation cohort, and 0.906 (0.871–0.934), 0.856 (0.815–0.890), 0.852 (0.811–0.887), and 0.832 (0.789–0.869) in the external validation cohort, respectively. To support clinical implementation, a web- and Android-based decision support system was developed and is currently undergoing pilot testing in multiple hospitals. Interpretation: We developed and validated an interpretable multi-task ML model capable of accurately predicting key clinical outcomes in patients with RM. To improve clinical applicability, a user-friendly decision support system was implemented, incorporating interactive features to support frontline healthcare providers in real-time risk stratification and individualized management of RM. Funding: National Key Research and Development Program of China (Nos. 2021YFC3002202 and 2023YFF1204104).
format Article
id doaj-art-054902b4a0c74c40b97d2308eb50938d
institution Kabale University
issn 2589-5370
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj-art-054902b4a0c74c40b97d2308eb50938d2025-08-22T04:57:15ZengElsevierEClinicalMedicine2589-53702025-09-018710343810.1016/j.eclinm.2025.103438Development and validation of an interpretable multi-task model to predict outcomes in patients with rhabdomyolysis: a multicenter retrospective cohort studyResearch in contextChunli Liu0Jie Shi1Fengjuan Wang2Duo Li3Yu Luo4Bofan Yang5Yunlong Zhao6Li Zhang7Dingwei Yang8Heng Jin9Jie Song10Xiaoqin Guo11Haojun Fan12Qi Lv13School of Disaster and Emergency Medicine, Tianjin University, Tianjin, ChinaSchool of Disaster and Emergency Medicine, Tianjin University, Tianjin, ChinaSchool of Disaster and Emergency Medicine, Tianjin University, Tianjin, ChinaSchool of Disaster and Emergency Medicine, Tianjin University, Tianjin, ChinaSchool of Disaster and Emergency Medicine, Tianjin University, Tianjin, ChinaSchool of Disaster and Emergency Medicine, Tianjin University, Tianjin, ChinaSchool of Disaster and Emergency Medicine, Tianjin University, Tianjin, ChinaDepartment of Nephrology, National Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Military Logistics Research Key Laboratory of Field Disease Treatment, Beijing Key Laboratory of Kidney Disease Research, First Medical Center of Chinese PLA General Hospital, Beijing, ChinaDepartment of Nephrology, Tianjin Hospital of Tianjin University, Tianjin, ChinaDepartment of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin, ChinaCharacteristics Medical Center of Chinese People's Armed Police Force, Tianjin, ChinaSchool of Disaster and Emergency Medicine, Tianjin University, Tianjin, China; Corresponding author.School of Disaster and Emergency Medicine, Tianjin University, Tianjin, China; Corresponding author.School of Disaster and Emergency Medicine, Tianjin University, Tianjin, China; Corresponding author.Summary: Background: Rhabdomyolysis (RM) is a complex clinical syndrome with heterogeneous progression patterns among patients of varying severity. Early and accurate prediction of acute kidney injury (AKI), disease severity, renal replacement therapy (RRT) requirements, and mortality risk is essential for timely identification of high-risk individuals, personalized treatment planning, and optimal allocation of healthcare resources. We aimed to develop and externally validate an interpretable multi-task machine learning (ML) model to predict four clinical outcomes in patients with rhabdomyolysis: AKI, disease severity, the need for RRT, and in-hospital mortality. Methods: We conducted a retrospective study using three data sources: the eICU Collaborative Research Database (eICU-CRD), the Medical Information Mart for Intensive Care IV (MIMIC-IV), and electronic medical records from four tertiary hospitals in China. Data from eICU-CRD and MIMIC-IV were combined to form the derivation cohort for model training and internal validation, while data from the Chinese hospitals served as the external validation cohort. We analyzed 1429 patients from 2008 to 2019 in the derivation cohort and 362 patients from 2016 to 2022 in the external validation cohort. AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria, based on serum creatinine levels and urine output. Twenty-two clinical features available within the first 24 h of admission were selected to develop the prediction models. Ten machine learning (ML) algorithms were applied to construct multi-task prediction models. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC). To improve interpretability, feature importance was assessed using the SHapley Additive exPlanation (SHAP) method. Findings: 1429 patients were included in the derivation cohort (69.4% developed AKI, 36.7% were classified as having severe disease, 12.1% required RRT, and 9.8% had in-hospital mortality). 362 patients were included in the external validation cohort (27.9% developed AKI, 25.7% had severe disease, 27.3% required RRT, and 4.1% had in-hospital mortality). Among all evaluated models, the random forest (RF) algorithm exhibited the highest overall discriminative performance across the four prediction tasks. Based on feature importance rankings, interpretable final models were developed for each task using the top five contributing features. These models demonstrated robust predictive accuracy for AKI, disease severity, RRT requirements, and in-hospital mortality, with AUCs and corresponding 95% confidence intervals (CIs) of 0.914 (0.875–0.944), 0.909 (0.869–0.940), 0.888 (0.844–0.921), and 0.823 (0.773–0.865) in the internal validation cohort, and 0.906 (0.871–0.934), 0.856 (0.815–0.890), 0.852 (0.811–0.887), and 0.832 (0.789–0.869) in the external validation cohort, respectively. To support clinical implementation, a web- and Android-based decision support system was developed and is currently undergoing pilot testing in multiple hospitals. Interpretation: We developed and validated an interpretable multi-task ML model capable of accurately predicting key clinical outcomes in patients with RM. To improve clinical applicability, a user-friendly decision support system was implemented, incorporating interactive features to support frontline healthcare providers in real-time risk stratification and individualized management of RM. Funding: National Key Research and Development Program of China (Nos. 2021YFC3002202 and 2023YFF1204104).http://www.sciencedirect.com/science/article/pii/S2589537025003700RhabdomyolysisAcute kidney injuryRenal replacement therapyMortalityMachine learningPrediction model
spellingShingle Chunli Liu
Jie Shi
Fengjuan Wang
Duo Li
Yu Luo
Bofan Yang
Yunlong Zhao
Li Zhang
Dingwei Yang
Heng Jin
Jie Song
Xiaoqin Guo
Haojun Fan
Qi Lv
Development and validation of an interpretable multi-task model to predict outcomes in patients with rhabdomyolysis: a multicenter retrospective cohort studyResearch in context
EClinicalMedicine
Rhabdomyolysis
Acute kidney injury
Renal replacement therapy
Mortality
Machine learning
Prediction model
title Development and validation of an interpretable multi-task model to predict outcomes in patients with rhabdomyolysis: a multicenter retrospective cohort studyResearch in context
title_full Development and validation of an interpretable multi-task model to predict outcomes in patients with rhabdomyolysis: a multicenter retrospective cohort studyResearch in context
title_fullStr Development and validation of an interpretable multi-task model to predict outcomes in patients with rhabdomyolysis: a multicenter retrospective cohort studyResearch in context
title_full_unstemmed Development and validation of an interpretable multi-task model to predict outcomes in patients with rhabdomyolysis: a multicenter retrospective cohort studyResearch in context
title_short Development and validation of an interpretable multi-task model to predict outcomes in patients with rhabdomyolysis: a multicenter retrospective cohort studyResearch in context
title_sort development and validation of an interpretable multi task model to predict outcomes in patients with rhabdomyolysis a multicenter retrospective cohort studyresearch in context
topic Rhabdomyolysis
Acute kidney injury
Renal replacement therapy
Mortality
Machine learning
Prediction model
url http://www.sciencedirect.com/science/article/pii/S2589537025003700
work_keys_str_mv AT chunliliu developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT jieshi developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT fengjuanwang developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT duoli developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT yuluo developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT bofanyang developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT yunlongzhao developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT lizhang developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT dingweiyang developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT hengjin developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT jiesong developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT xiaoqinguo developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT haojunfan developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext
AT qilv developmentandvalidationofaninterpretablemultitaskmodeltopredictoutcomesinpatientswithrhabdomyolysisamulticenterretrospectivecohortstudyresearchincontext